Authors: Rob Hirst, Becky Maxwell, Chris Connolly, Dave McCreary, Andy Neill / Codes: ObC19, RP6, SLO10, SLO11, SLO3, XC3 / Published: 08/04/2025
Title - Landiolol for heart rate control in patientswith septic shock and persistent tachycardia. Amulticenter randomized clinical trial (Landi-SEP)
Author - Rehberg, ICM, 2024
Background - Sepsis is really common and kills lots of people, so that's the epidemiology and public health bit covered. In terms of patho phys, we know there are lots of "dysregulated" reactions in the body to sepsis. There have been many drugs trialled to see if we can dampen down that dysregulated response and so far they've not panned out. Beta blockers are next up. This paper comes on the background of a prior small paper that suggested given beta blockers may improve mortality. The obvious biologic plausibility one is tachycardia, if you're going too fast then you've no time in the cardiac cycle to fill well and this might impair cardiac output and perfusion of the coronary arteries. Well, that is the theory at least. There may be many other reasons why beta blockers might be good for what ails you too. To avoid the negative inotropic properties for most beta blockers they use super selective beta 1 antagonists in these papers like esmolol that we've likely heard of or landilol that, like me, you probably haven't
Methods - MCRCT aross 7 countries in Europe - septic shock with HR >95 as inclusion (95 chosen as it was a previous increment point for mortality in observational work). There was an allowance for "compensatory tachycardia" to be excluded but that sounds like a good point for fudging. - open label with no good reason that I can see. (they say "due to an absence of a specific treatment in the control group" but I was always of the opinion that was perfect for placebo? - Lanidilol had infusion dose varied to keep HR<95 till pressors stopped. - The outcome was "multi component" as a wat of combining physiological outcomes of HR control and pressor requirement. Hardly ideal. - I did noy see a power calculation.
Results - 200 pts - 40% primary outcome in landilol group vs 24% in the control group - no changes in mortality -65% adverse event rate reported in both groups.
Thoughts - not sure this adds much. It seems relatively safe but what's the point simply to correct a number? - as they highlight it would be helpful to have cardiac output data as the putative rationale here is largely haemodynamic and it's not clear if beta blocker actually changed the haemodynamics here.
Related Posts
Supporting Overseas Doctors (IMGs)
There are many components of looking after overseas doctors. Many of them are intuitive and seem common sense, but our experience suggests the basics are often done poorly. We define an overseas doctors as a doctor who has trained, and probably worked, abroad who is embarking on a new healthcare career in the NHS.
August 2021
This month we have a slightly different format. Andy and Dave are here with 3 New in EM and Becky and Chris join us for a guideline review. We discuss Are you learning from Podcasts While Driving?, metoclopramide for post traumatic headache, EM Pain Management and Awareness and paralysis with intubation in the ED
Coronavirus, (COVID19) tips and resources
RCEMLearning Coronavirus, COVID19, tips and resources